Researchers identified TIMP2 as a key factor supporting healthy microglial function in the aging brain. Restoring TIMP2 in aged mice improved microglia's ability to clear debris and reduced inflammation, suggesting potential therapeutic strategies for neurodegenerative disorders.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Communications·TypeExperimental study·DateAug 14, 2026
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
According to a national survey commissioned by The Ohio State University Wexner Medical Center, most U.S. adults believe brain health habits should begin before age 40. Regular exercise, quality sleep, healthy eating, and strong social connections can help support long-term brain health.
SourceOhio State University Wexner Medical Center·TypeSurvey·DateAug 12, 2026
Researchers at UH College of Pharmacy are developing breakthroughs to combat sepsis, a leading cause of hospital deaths, and diseases such as Alzheimer's and sickle cell disease. A dual-action nanomedicine has shown a 100% survival rate in preclinical trials for sepsis treatment.
Researchers developed a novel imaging approach called SANDI to study microstructural brain abnormalities associated with Huntington's disease. The model revealed differences in cell density and size, correlating with disease progression and motor performance.
SourceeLife·JournaleLife·TypeExperimental study·DateAug 11, 2026
Researchers at UC San Diego identified a key cellular pathway that drives brain degeneration in both Sanfilippo syndrome type A and Alzheimer's disease. The study reveals how the brain's immune cells respond to waste buildup, providing a novel target for drug development.
SourceUniversity of California - San Diego·JournalImmunity·DateAug 11, 2026
Researchers at Weill Cornell Medicine have identified structural changes that enable the LRRK2 protein to become overactive, a key step in Parkinson's disease progression. Understanding these changes is crucial for developing targeted therapies to slow or halt the disease.
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers found that exercise-induced molecular changes contribute to neuronal health, improving movement and quality of life in PD patients. Exercise types such as aerobic exercises, resistance training, balance training, and multimodal exercise were found to be helpful in reducing falls, disabilities, and improving brain function.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeLiterature review·DateAug 7, 2026
A study by Stanford Medicine scientists reveals that wayward tau molecules can gum up mitochondria's internal energy-production lines, initiating a vicious cycle of pathological events. This discovery provides a new mechanism driving tauopathies and renders these disorders amenable to new therapeutic interventions.
The first complete marmoset genome is now available, providing a high-quality reference for studying complex diseases like Alzheimer's. The new genome reveals variation in genes linked to Alzheimer's disease, as well as immune system genes and previously un-catalogued ribosomal DNA genes.
SourceUniversity of California - Santa Cruz·JournalCell·DateAug 6, 2026
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
The Boston University-Quantitative Population Science and Healthy Cognitive Aging Research Program (BU-SHARP) aims to better understand how and why Alzheimer's disease manifests among certain populations. The center will fund pilot studies, provide technical assistance, and facilitate access to underutilized datasets.
SourceBoston University School of Public Health·DateAug 5, 2026
Researchers at Stanford University discovered that aging brings a large influx of immune cells into the brain, upending previous assumptions about the brain's immune system. The study suggests that these immune cells may interact with the brain and contribute to its resilience against Alzheimer's disease.
SourceStanford University·JournalNature·TypeObservational study·DateAug 5, 2026
Researchers used real human brain tissue samples to test the underlying mechanisms of deep brain stimulation. They found that brain cells became more synchronized in communicating, similar to memory formation, while altering gene expression across different types of brain cells.
SourceUniversity of California - Los Angeles Health Sciences·JournalNature·TypeExperimental study·DateAug 5, 2026
A new report finds that delayed discharges and poor hospital environments keep people with dementia in hospitals unnecessarily, costing £328 million annually. The study suggests community-centric approaches can reduce hospitalisations and improve care.
SourceUniversity College London·JournalAlzheimer s & Dementia·DateAug 4, 2026
A new USC study uses AI to generate detailed maps of brain aging, revealing distinct patterns of neurodegeneration in specific regions. The approach sheds light on how local brain age correlates with changes in cognitive function across the lifespan.
SourceUniversity of Southern California·JournalProceedings of the National Academy of Sciences·TypeImaging analysis·DateAug 3, 2026
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
Researchers have identified a new type of brain plaque, called mitochondrial plaques, that may emerge at the earliest stages of Alzheimer's disease. These plaques contain high levels of amyloid precursor protein and can directly affect neurons, making them a potential target for new treatments.
SourceUniversity of Minnesota Medical School·JournalNature Neuroscience·TypeObservational study·DateJul 30, 2026
Researchers at the University of Illinois developed a gene editing tool to treat Huntington's disease by altering a specific point in the huntingtin gene. The treatment reduced toxic protein fragments, symptoms, and brain degeneration in mice, providing a new approach for treating genetic diseases.
SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalNature Biomedical Engineering·TypeExperimental study·DateJul 29, 2026
Researchers have identified a panel of key proteins in blood that can predict the emergence of ALS symptoms months to years before they arise. This discovery could enable early intervention with preventative therapies.
SourceNIH/Office of the Director·JournalNature Medicine·DateJul 27, 2026
A study found that brain immune cells undergo substantial remodeling in midlife, leading to chronic neuroinflammation and potential dementia risk. The research used advanced single-cell analysis techniques to analyze postmortem hippocampal tissue from 40 healthy adults.
SourceNIH/Office of the Director·JournalScience·DateJul 23, 2026
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
Researchers found that bee venom can improve motor function and cognitive decline in a mouse model of Parkinson's disease when used alongside conventional therapy. The study suggests promising benefits for developing adjunct therapies to improve treatment outcomes.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeExperimental study·DateJul 22, 2026
Researchers developed a new methodology using artificial intelligence to analyze brain electrical activity during sleep, identifying early neural alterations and classifying patients into distinct biological subgroups. This non-invasive approach may facilitate earlier diagnosis of Alzheimer's disease.
SourceUniversidad Carlos III de Madrid·JournalGeroScience·DateJul 22, 2026
Researchers identify a specialized lymphatic network in the brain that enables cerebrospinal fluid drainage, which declines with age but can be restored through intranasal VEGF-C delivery. This discovery provides new insights into brain waste clearance and its link to neurodegenerative disorders.
SourceInstitute for Basic Science·JournalCell·TypeExperimental study·DateJul 22, 2026
A new study by Sanford Burnham Prebys found that bolstering the SORLA protein can reduce tau tangle toxicity, a common culprit in Alzheimer's disease and other neurodegenerative disorders. This suggests potential as a therapeutic strategy for treating these conditions.
SourceSanford Burnham Prebys·JournalScience Advances·TypeExperimental study·DateJul 17, 2026
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
Researchers found that tau buildup in PSP affects brain networks involved in thinking, including the prefrontal cortex and anterior cingulate cortex. The study suggests that symptoms arise from both local tau-related damage and remote disruption of a broader cognitive network.
SourceThe National Institutes for Quantum Science and Technology·JournalScience Advances·TypeImaging analysis·DateJul 17, 2026
Researchers at Kyoto University discovered an RNA aptamer, 1R6, that targets the disordered regions of alpha-synuclein protein, inhibiting its aggregation and promoting disassembly of pre-existing aggregates. This finding offers a new therapeutic strategy for neurodegenerative disorders like Parkinson's disease.
SourceKyoto University·JournalNature Communications·TypeExperimental study·DateJul 16, 2026
A scoping review suggests astrocytic dysfunction may precede neuronal degeneration in CTE. Astrocytes' dysregulation contributes to the development of CTE's characteristic features through mechanisms including astrogliosis, disrupted waste clearance pathways, and chronic neuroinflammation.
SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeLiterature review·DateJul 15, 2026
Researchers at Texas A&M University have found a way to intervene early in traumatic brain injuries using a natural, gut-derived chemical that prevents post-traumatic epilepsy from taking root. The treatment reduced brain inflammation, improved memory and mood, protected brain cells, made seizures both rarer and harder to trigger.
SourceTexas A&M University·JournalExperimental Neurology·DateJul 15, 2026
A blood test measuring phosphorylated tau 217 (P-tau217) can estimate an individual's risk of developing cognitive impairment over 2, 5, and 10 years. Higher P-tau217 levels are associated with increased risk of progression to cognitive impairment in cognitively unimpaired older adults.
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
Researchers discovered that reducing microglial activity worsened abnormal electrical activity and increased seizure-like events in a mouse model of Alzheimer's disease. Microglia are not just drivers of inflammation but also perform important housekeeping functions to maintain healthy brain activity.
SourceTrinity College Dublin·JournalBrain·TypeExperimental study·DateJul 15, 2026
The University of Cincinnati launches the Center for Alzheimer's and Neurodegenerative Diseases Research (CANDR) to improve dementia prevention and treatment outcomes. CANDR aligns with UC's mission to innovate and engage locally while addressing one of the region's most pressing public health challenges.
A new study published in the Journal of Alzheimer's Disease estimates that dementia-related costs across 30 high-income European countries total €221 billion annually. Family caregivers carry a significant portion of this burden, providing an estimated €128 billion in unpaid care.
SourceBeyond·JournalJournal of Alzheimer’s Disease·DateJul 13, 2026
A University of Houston chemist is uncovering how copper imbalances in neurons contribute to neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS. The new imaging technique provides a closer look at individual protein behaviors inside living cells, giving researchers insight into the cellular pathways that fail.
A large USC study of over 214,000 older adults across 14 countries found that controllable dementia risk factors such as low education and high blood pressure differ significantly from country to country. The study's findings suggest a one-size-fits-all approach to prevention may not be effective everywhere, and highlight the importanc...
SourceUniversity of Southern California·JournalThe Lancet Healthy Longevity·TypeData/statistical analysis·DateJul 12, 2026
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
The University of California, San Francisco is launching a novel clinical trial to test a combination of therapies for the most common form of Alzheimer's disease. The trial will enroll up to 825 participants and test drugs that target both amyloid and tau proteins, with the goal of slowing disease progression.
SourceUniversity of California - San Francisco·DateJul 9, 2026
The REGEN4HD study marks a significant milestone in the development of regenerative medicine approaches for Huntington's disease. The Phase 1b/2a trial enrolls early-stage symptomatic patients to evaluate safety and tolerability.
SourceInternational Society for Stem Cell Research·DateJul 9, 2026
Researchers discovered that damaged myelin generates abnormal rhythms in the sleeping brain, linked to disruptions in brain circuit stability. This finding may help design non-invasive approaches to repair myelin during sleep, improving sleep quality in patients with MS and Alzheimer's disease.
SourceFederation of European Neuroscience Societies·TypeExperimental study·DateJul 9, 2026
The STEM-PD trial demonstrated the safety and feasibility of stem cell-derived dopaminergic cell transplantation in patients with moderate to advanced Parkinson's disease. The findings mark an important step in evaluating this approach as a potential treatment strategy for neurodegenerative diseases.
SourceInternational Society for Stem Cell Research·DateJul 9, 2026
A new $250,000 grant will support the development of a novel therapeutic approach for sepsis-associated neurocognitive dysfunction. The treatment aims to protect the brain from inflammation-related damage during and after sepsis, potentially preventing or slowing neurodegeneration and cognitive decline.
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
Researchers at ISSCR 2026 present interim clinical findings from the first Phase 1/2a trial of autologous iPSC-derived dopamine neuron precursor cells for Parkinson's disease. The approach uses each patient's own cells, and new genomic quality control methods ensure the manufactured cells are suitable for transplantation.
SourceInternational Society for Stem Cell Research·DateJul 9, 2026
A new study describes a gene therapy strategy that uses the brain's glymphatic transport system to distribute engineered viral vectors throughout the brain. This approach enables preferential targeting of human glial cells while minimizing exposure to other cell types and organs, addressing two major challenges in neurological medicine.
SourceUniversity of Rochester Medical Center·JournalNature Biotechnology·DateJul 8, 2026
Scientists at King's College London have developed a human-safe drug that repairs DNA breaks and reduces inflammation in a mouse model of Alzheimer's disease. This approach targets multiple features of the disease simultaneously, providing a broader therapeutic strategy than previous approaches focused on individual disease hallmarks.
SourceKing's College London·JournalFEBS Open Bio·TypeExperimental study·DateJul 8, 2026
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
Research suggests alcohol interacts with Alzheimer's-related brain circuits in distinct ways, depending on the type of pathological change. Alcohol reduced communication in amyloid-beta models but increased it in tau models, highlighting an important principle in biology.
SourceTexas A&M University·JournalNeuropharmacology·DateJul 8, 2026
Researchers found that KCL-286 enhances DNA repair and reduces neuronal inflammation in a mouse model of Alzheimer's disease. The drug activates the retinoic acid receptor-beta pathway, promoting the expression of certain repair genes.
Glial cells play critical roles in determining brain recovery after TBI, and researchers have identified ways to selectively modulate their functions. The study highlights the importance of coordinated cellular behavior and suggests that targeting glial responses could lead to effective therapies.
SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateJul 8, 2026
Davis Instruments Vantage Pro2 Weather Station
Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.
Researchers developed a human-safe drug that repairs DNA breaks and reduces inflammation in a mouse model of Alzheimer's disease. The approach targets multiple disease-relevant cellular pathways, providing a broader therapeutic strategy than previous approaches focused on individual disease hallmarks.
SourceKing's College London·JournalFEBS Open Bio·TypeExperimental study·DateJul 8, 2026
Research found that Parkinson's disease triggers shared 'stress responses' but also differs between men and women at the cellular level, particularly in how glial cells manage energy and protect nerve connections. This discovery may lead to more personalized treatments for patients.
SourceFederation of European Neuroscience Societies·TypeObservational study·DateJul 7, 2026
Researchers at King's College London discovered a molecule linked to chronic inflammation disrupts brain neuron formation, highlighting a pathway with therapeutic potential for conditions like Alzheimer's disease and depression. High cytokine levels trigger an 'immune alert' state, reducing new nerve cell production.
SourceKing's College London·JournalNature·DateJul 7, 2026
A new study links tire pollution to Alzheimer's disease through the exposure to 6PPD-quinone, a chemical formed from shaved-off tire particles. The researchers used computational methods to identify key genes that predict Alzheimer's disease and found strong binding of 6PPD-quinone to these genes.
SourceDe Gruyter Brill·JournalOpen Medicine·TypeComputational simulation/modeling·DateJul 6, 2026
Researchers at University of Arizona have found a promising new approach to slow fatal nerve disease ALS by blocking a small part of a key protein. The experimental drug XL20 protects nerve cells and reduces muscle weakness in mice and human nerve cells, representing a potential breakthrough.
SourceUniversity of Arizona·JournalNature Aging·TypeExperimental study·DateJul 3, 2026
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
Researchers propose a theoretical framework linking rubidium ion metabolic dysregulation to Parkinson's disease, highlighting the role of ionic homeostasis imbalance in neurodegeneration. Rubidium may serve as a potential biomarker and therapeutic target for early intervention.
SourceChina Association of Chinese Medicine, eTM·JournalWorld Journal of Integrated Traditional and Western Medicine·TypeData/statistical analysis·DateJul 3, 2026
A USC interdisciplinary team has identified a promising pathway to turn off brain inflammation before it does its damage, increasing the risk of late-onset Alzheimer's. The Norman and Mary Pattiz Foundation funding will support research on novel drug discovery, early detection, and prevention of Alzheimer's disease.
Researchers have improved analysis of molecules linked to Alzheimer's disease by using higher magnetic fields, enabling the study of complex mixtures and identifying atomic-level clues. This finding could aid the development of future treatments for the disease.
SourceFlorida State University·JournalSolid State Nuclear Magnetic Resonance·DateJul 1, 2026
Researchers discovered that a brain protein called Arc helps spread toxic Tau from sick brain cells to healthy ones in mice. This finding suggests that targeting the spread of Tau could be a powerful tool to stop Alzheimer's disease progression. The study also highlights the potential protective role of Arc in early stages of the disease.
SourceUniversity of Utah Health·JournalCell·TypeExperimental study·DateJun 29, 2026
Research suggests exposure to extreme heat and cold increases risk of emergency department visits among people with dementia. Extreme temperatures accelerate health events that would otherwise occur later, potentially leading to increased healthcare demand.
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
Research presented at the European Academy of Neurology Congress 2026 found that women with Parkinson's disease had significantly greater amyloid plaque burden and neuritic plaque density compared to men. The study suggests that women may be more susceptible to Alzheimer's-related changes in the brain.
Researchers at Texas A&M University develop a laser technique called TRIP to directly measure quantum forces shaping proteins, enabling accurate prediction of how pharmaceutical drugs interact with them. This breakthrough could lead to the design of medicines tailored to specific diseases, revolutionizing precision medicine.
SourceTexas A&M University·JournalScience Advances·DateJun 25, 2026
Researchers identified karyoptosis as a key link between toxic protein accumulation and neuron death in neurodegenerative diseases like Alzheimer's and frontotemporal dementia. The study found that targeting proteins acting as 'switches' in this pathway may slow or prevent cell death by karyoptosis.
SourceKing's College London·JournalNature Communications·TypeExperimental study·DateJun 25, 2026
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
Salk Institute researchers discovered chronoferroptosis, a chronic stress pathway in cells that causes neurons to become less resilient over time and more susceptible to neurodegeneration. Iron accumulation was found to lower the cells' defenses, making them more vulnerable to stressors.
SourceSalk Institute·JournalCell Death Discovery·DateJun 25, 2026
Researchers study blind Mexican cavefish to understand how evolution rewires the brain and shapes behavior. They found that cavefish become more active in light, a response believed to help them avoid predators.
SourceFlorida Atlantic University·JournalScience Advances·TypeExperimental study·DateJun 24, 2026
Researchers developed zebrafish model that reproduces key features of CADASIL, a hereditary disease causing brain damage and recurrent strokes. The study found progressive decline in cerebral blood flow and impaired learning ability, similar to human patients.
SourceChiba University·JournalActa Neuropathologica Communications·TypeExperimental study·DateJun 24, 2026
Researchers at UCI Health have begun the world's first clinical trial for Huntington’s disease using neural stem cells. The phase 1b/2a trial aims to evaluate the safety and potential benefits of this innovative therapy, which could slow disease progression and reduce long-term care costs.
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.